LON:ABC - Abcam Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started GBX 1,371 -13.00 (-0.94 %) (As of 07/22/2018 06:59 AM ET)Previous CloseGBX 1,371Today's RangeGBX 1,363 - GBX 1,40252-Week RangeGBX 9.73 - GBX 1,290Volume299,095 shsAverage Volume497,233 shsMarket Capitalization£2.60 billionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileAnalyst RatingsDividend HistoryInsider TradesHeadlinesChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom. Receive ABC News and Ratings via Email Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical SymbolLON:ABC CUSIPN/A Webwww.abcam.com Phone+44-1223-696000 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins19.67% Return on Equity15.03% Return on Assets12.58% Miscellaneous EmployeesN/A Outstanding Shares204,640,000Market Cap£2,600.00 Abcam (LON:ABC) Frequently Asked Questions What is Abcam's stock symbol? Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC." How often does Abcam pay dividends? What is the dividend yield for Abcam? Abcam announced a dividend on Monday, March 5th. Investors of record on Thursday, March 15th will be given a dividend of GBX 3.42 per share on Thursday, April 12th. This represents a yield of 0.28%. The ex-dividend date of this dividend is Thursday, March 15th. The official announcement can be accessed at this link. View Abcam's Dividend History. What price target have analysts set for ABC? 5 equities research analysts have issued 1 year target prices for Abcam's shares. Their predictions range from GBX 1,011 to GBX 1,380. On average, they expect Abcam's share price to reach GBX 1,180.25 in the next twelve months. This suggests that the stock has a possible downside of 13.9%. View Analyst Ratings for Abcam. What is the consensus analysts' recommendation for Abcam? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." Who are some of Abcam's key competitors? Some companies that are related to Abcam include ABLYNX NV/ADR (ABLX), MorphoSys (MPSYY), BTG (BTG), MorphoSys (MOR), Almirall (LBTSF), Sosei Group (SOLTF), Sirtex Medical (SRX), Genus (GNS), Biotest (BIO), ProMetic Life Sciences (PLI), Genfit (GNFTF), Mesoblast (MSB), Theratechnologies (TH), Mesoblast (MEOBF) and Emerald Health Therapeutics (EMH). Who are Abcam's key executives? Abcam's management team includes the folowing people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 50)Dr. Jonathan Simon Milner, Co-Founder and Non-Exec. Deputy Chairman (Age 53)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 48)Mr. Mark Bushfield Ph.D., Scientific DirectorMr. Sean Hickey BSc, Chief Information Officer Has Abcam been receiving favorable news coverage? News stories about ABC stock have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Abcam earned a news sentiment score of 0.15 on Accern's scale. They also gave news coverage about the company an impact score of 47.71 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. How do I buy shares of Abcam? Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Abcam's stock price today? One share of ABC stock can currently be purchased for approximately GBX 1,371. How big of a company is Abcam? Abcam has a market capitalization of £2.60 billion. How can I contact Abcam? Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000. MarketBeat Community Rating for Abcam (LON ABC)Community Ranking: 1.2 out of 5 ()Outperform Votes: 130 (Vote Outperform)Underperform Votes: 411 (Vote Underperform)Total Votes: 541MarketBeat's community ratings are surveys of what our community members think about Abcam and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What do I need to know about analyst ratings?